Home>Topics>>Vivus Rallies After Aetna Drug Policy Change
Vivus Rallies After Aetna Drug Policy Change
Healthcare Sector and Stocks Analysis from Seeking Alpha
Wed, 21 Nov 2012
By EXPstocktrader : Aetna ( AET ) stated in a Clinical Policy Bulletin revision that has contributed to the rise in Vivus ( VVUS ) stock this morning. Dated November 20, 2012, Aetna said that specified criteria under which the insurer considers weight reduction medications as " medically necessary ...
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.